Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.
Monsanto and others look to RNA interference to fight widespread bee-killing mites.
MIT professor shares an update about his work in cancer research at the Koch Institute.
A unique class of RNA drugs could bring new treatments to cancer and other diseases.
The decision should reduce uncertainty in the field of molecular diagnostics.
The technique could help patients with currently untreatable diseases such as Huntington’s.
A biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
A new study reveals the influence of large RNA molecules in controlling stem cells.
Repetitive stretches of RNA are found in high concentrations in cancer cells.